Right atrial thrombi are usually immobile. However, a mobile type mimicking a cardiac tumor, especially myxoma, has been described on rare occasions. We report here a case of atrial thrombus which was mobile in the cardiac chambers. A 29-year-old male was admitted because of exertional dyspnea. On admission, his echocardiogram showed an abnormal mass in the right atrium with a stalk attached to the interatrial septum. It decreased in size on the next day. On the fourth day of admission, it moved to the right ventricle. Multiple pulmonary emboli were revealed by the lung perfusion scintigram. Two days after the administration of intravenous urokinase, the abnormal mass in the cardiac chambers was no longer seen on the echocardiogram. This was a rare case of mobile atrial thrombus associated with multiple pulmonary emboli. Thrombolytic therapy appeared to be effective in this case.
Thrombolytic therapy was started. After urokinase was administered at a dose of 960,000units/day for 5 days followed by 480,000units/day for a subsequent 4 days, a subsequent echocardiogram no longer showed any abnormal mass in either the right ventricle or right atrium.
Lung perfusion scintigraphy demonstrated reestablishment of perfusion in S1+2,3,6 in the left lung and S3,5,6 in the right lung. He was treated with warfarin thereafter. The pulmonary artery angiogram ( 
DISCUSSION
This case showed a myxoma-like mobile mass on the echocardiogram. Based on the patient's past history of deep venous thrombosis and the effect of thrombolytic therapy on lung perfusion scintigraphy, we suspected right atrial thrombus rather than myxoma.
Right atrial thrombi can be classified into immobile and mobile thrombi.1) The former are usually associated with conditions causing dilatation of the right atrium, decreased cardiac output, relative stasis of blood such as in cardiomyopathies, atrial fibrillation or following repair of atrial septal defects, and intracardiac catheters. In contrast, mobile thrombi usually originate from the leg veins or inferior vena cava and are entrapped in the right atrium during their transition to the lung.
Right atrial myxomas may be confused with mobile right atrial thrombi.
However, myxomas have a mottled, ovoid, and sharply demarcated appearance and commonly attach to the interatrial septum and occasionally prolapse across the tricuspid valve during diastole. In this case, the mass had an ovoid shape and appeared to be attached to the interatrial septum by a stalk. These findings mimicked myxoma, but the heterogeneous echo density with an irregular surface suggested thrombus rather than myxoma.
In reviewing the literature we found 57 cases with right atrial mobile thrombus reported during the past 9 years,2)-16) including 4 cases from Japan.14)-16) In these 4 cases, 2 patients died suddenly. The thrombus disappeared in the remaining 2 cases after the administration of warfarin or heparin.
Thus, right atrial mobile thrombus has been rarely seen in Japan, and its pathogenesis, natural course, and management are not well known.
In this case, because the mass moved from the right atrium to the right ventricle during the first few days after the patient's admission, recurrence of pulmonary emboli was highly possible. Medical treatment for pulmonary emboli is generally thrombolytic therapy combined with the use of anticoagulant drugs. However there has been no standard for the use of thrombolytic agents. A national cooperative study from the United States recommends an intravenous infusion of urokinase, given as a loading dose of 4,400units/kg followed by 4,400units/kg/hr for the subsequent 12hrs.17) In Japan the doses of urokinase generally administered for pulmonary emboli are 240,000-720,000 units for a mean of 4.8 days.18) Watanabe et al19) reported a case of multiple pulmonary emboli successfully treated with large doses of urokinase (total dose of 7,080,000 units over 10 days). Our patient received a total dose of 6,720,000 units of urokinase over 9 days with significant improvement in both clinical and laboratory findings. Table I summarizes the 52 cases, from the 57 cases described in the literature, in whom the thrombus disappeared from the right atrium over time. Thrombolytic therapy was given in 19.2% of the 52 cases, with or without anticoagulant therapy and was effective in 70% of them, resulting in disappearance of thrombus without death. Accordingly, thrombolytic therapy seems to be effective for right atrial mobile thrombus as well as for pulmonary emboli.
